BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength

Bausch Health posts mixed Q1: EPS misses, but revenues beat estimates on strong Salix and Solta growth. Pipeline progress and the raised 2026 view add momentum.
Open original source